Medicare Regulatory Attorney Jayson Slotnik Joins Foley Hoag's Life Sciences Practice
Washington, D.C. - November 23, 2009
Mr. Slotnik, former director of Medicare-Medicaid reimbursements at Biotechnology Industry Organization joins Foley Hoag
Adding to its leading team of life sciences regulatory attorneys and policy specialists, Foley Hoag LLP announced that Jayson Slotnik, a former director of Medicare and Medicaid reimbursements at the Biotechnology Industry Organization, has joined the firm’s Government Strategies practice in Washington, DC.
Mr. Slotnik arrives from the Washington office of Hogan & Hartson, where he counseled clients on Medicare and Medicaid coverage, as well as reimbursement and coding issues covering medical devices, diagnostic tests, drugs, and biologics. He becomes Of Counsel at Foley Hoag.
At BIO, the principal trade organization for the global biotech industry, Mr. Slotnik served for three years (2004-2007) as Director for Medicare Reimbursement and Economic Policy. At BIO, Mr. Slotnik handled matters relating to Medicare coverage, coding and payment of drugs and biologics. He was regularly called on to testify before the Center for Medicare & Medicaid Services, as well as interact with Congressional staff regarding payment policy proposals. In addition to advising members on reimbursement strategies, Mr. Slotnik counseled BIO members on business development issues and worked with membership and affiliate groups to develop reimbursement policies on complex diagnostic tests and other medical therapies.
“Jayson Slotnik is another huge addition to our health care and life sciences bench. He is extremely well versed in the key regulatory challenges facing the biotech industry and has an expansive knowledge of Medicare and Medicaid reimbursement issues,” said Brian Carey, head of the regulatory group within Foley Hoag’s Government Strategies practice. “His expertise fits perfectly with the needs of our life sciences clients who seek to develop and market new breakthrough products and treatments.”
Mr. Slotnik also has extensive private sector health care experience. Prior to law school, he was a project manager for a consulting firm focused on epidemiology and occupational health, where he designed scientific studies regarding indoor air quality, hospital mortality rates, and Fen-Phen-related injuries. He spent time as a senior analyst for a legislative firm, monitoring Medicaid and Medicare programs for healthcare technology clients. He was also a reimbursement analyst for a pharmaceutical consulting firm, reporting on federal and state Medicare and Medicaid programs and other government reimbursement policies.
Mr. Slotnik received his J.D. from the University of Maryland School of Law, his Master’s in Public Health from George Washington University and his B.A. from Rochester University.
Foley Hoag’s Government Strategies practice is active on both the state and federal levels. Lawyers in the practice, located in Boston and Washington, work with clients in regulated industries to achieve mutually beneficial solutions to public policy issues. Foley Hoag’s Government Strategies lawyers have worked in senior-level positions within presidential administrations, on Capitol Hill, in regulatory agencies, and in industry trade associations. The firm’s Life Sciences practice provides a full range of services including Patent Litigation, Prosecution and Strategy; Corporate Finance and Securities; Mergers, Acquisitions and Strategic Alliances; FDA and Reimbursement; Government Strategies; Venture Capital and Emerging Companies, and Product Liability and Complex Tort.
About Foley Hoag LLP
Foley Hoag is a dynamic law firm that represents public and private clients in a wide range of disputes and transactions worldwide. We have expertise in industries such as life sciences and healthcare, technology, energy and renewables, investment management, and professional services. We also offer our clients market-leading international litigation and arbitration and corporate social responsibility services. From our offices in Boston, Washington, D.C. and Paris, and our Emerging Enterprise Center in Waltham, Massachusetts, we provide strategic legal advice that is tailored to each of our clients' unique goals. Foley Hoag combines powerful regional, national and international practices that share a common emphasis on client service. We are focused on what we do best: helping our clients succeed through the delivery of exceptional legal service. For more information, visit www.foleyhoag.com.
CATEGORIES
Healthcare, Life Sciences, Government Strategies, Medicare Coverage & Reimbursement